Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
ROADMAP
Neuronet convenes annual event on European research collaboration in Alzheimer’s disease & beyond
Neuronet, a coordination and support action funded by the Innovative Medicines Initiative (IMI), brings together
Conducting public involvement in dementia research
Dementia outcomes include memory loss, language impairment, reduced quality of life and personality changes. Research
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Neuronet convenes 7th meeting of its Scientific Coordination Board
On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
3-dimensional representation of European data availability landscape for Alzheimer’s disease research
The Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access
Neuronet says farewell to Diana O’Rourke and welcomes Fatima Salih to the team
On 26 September 2021, Diana O’Rourke left her position as Senior Analyst at the National
The Innovative Medicines Initiative’s impact on dementia – presentations online!
The Innovative Medicines Initiative (IMI) organised a series of online live sessions on its impact.
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to
Alzheimer’s disease treatments: The Need for a Holistic Approach
As part of the latest digital supplement to Value & Outcomes Spotlight, the International Society